
Assessing breast MRI scans, pathology and clinical data, the AI-powered TumorSight Risk software reportedly provides five- and 10-year risk for breast cancer recurrence for women with HR+, HER2-negative stage I-IIIA breast cancer.
Review the case study and test your knowledge to make the correct diagnosis.
Case submitted by Araceli Cabanillas M.D., via
A patient presents with acute pain in the Achilles tendon region. What does the MRI reveal?





